A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors
- PMID: 15313885
- DOI: 10.1158/0008-5472.CAN-03-4061
A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors
Abstract
Whereas accepted models of tumorigenesis exist for genetic lesions, the timing of epigenetic alterations in cancer is not clearly understood. We have analyzed the profile of aberrations in DNA methylation occurring in cells lines and primary tumors of one of the best-characterized mouse carcinogenesis systems, the multistage skin cancer progression model. Initial analysis using high-performance capillary electrophoresis and immunolocalization revealed a loss of genomic 5-methylcytosine associated with the degree of tumor aggressiveness. Paradoxically, this occurs in the context of a growing number of hypermethylated CpG islands of tumor suppressor genes at the most malignant stages of carcinogenesis. We have observed this last phenomenon using two approaches, a candidate gene approach, studying genes with well-known methylation-associated silencing in human tumors, and a mouse cDNA microarray expression analysis after treatment with DNA demethylating drugs. The transition from epithelial to spindle cell morphology is particularly associated with major epigenetic alterations, such as E-cadherin methylation, demethylation of the Snail promoter, and a decrease of the global DNA methylation. Analysis of data obtained from the cDNA microarray strategy led to the identification of new genes that undergo methylation-associated silencing and have growth-inhibitory effects, such as the insulin-like growth factor binding protein-3. Most importantly, all of the above genes were also hypermethylated in human cancer cell lines and primary tumors, underlining the value of the mouse skin carcinogenesis model for the study of aberrant DNA methylation events in cancer cells.
Similar articles
-
Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.Cancer Res. 2003 Oct 1;63(19):6178-86. Cancer Res. 2003. PMID: 14559801
-
Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.Oncogene. 2006 Aug 31;25(39):5436-45. doi: 10.1038/sj.onc.1209530. Epub 2006 Apr 10. Oncogene. 2006. PMID: 16607278
-
Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.Hum Mol Genet. 2004 Nov 15;13(22):2753-65. doi: 10.1093/hmg/ddh298. Epub 2004 Sep 22. Hum Mol Genet. 2004. PMID: 15385438
-
Methylation of tumor suppressor genes p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis.Oral Oncol. 2006 Jan;42(1):5-13. doi: 10.1016/j.oraloncology.2005.03.016. Epub 2005 Jun 22. Oral Oncol. 2006. PMID: 15978859 Review.
-
DNA methylation and gene silencing in cancer: which is the guilty party?Oncogene. 2002 Aug 12;21(35):5380-7. doi: 10.1038/sj.onc.1205598. Oncogene. 2002. PMID: 12154400 Review.
Cited by
-
A timely, user-friendly analysis of the mouse DNA methylome.Cell Genom. 2022 Jul 13;2(7):100153. doi: 10.1016/j.xgen.2022.100153. eCollection 2022 Jul 13. Cell Genom. 2022. PMID: 36776781 Free PMC article.
-
RhoC in association with TET2/WDR5 regulates cancer stem cells by epigenetically modifying the expression of pluripotency genes.Cell Mol Life Sci. 2022 Dec 5;80(1):1. doi: 10.1007/s00018-022-04645-z. Cell Mol Life Sci. 2022. PMID: 36469134 Free PMC article.
-
Inheritance of common diseases.Biomedica. 2022 May 1;42(Sp. 1):5-7. Biomedica. 2022. PMID: 35866724 Free PMC article. English, Spanish. No abstract available.
-
Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma.Int J Mol Sci. 2022 Mar 23;23(7):3478. doi: 10.3390/ijms23073478. Int J Mol Sci. 2022. PMID: 35408839 Free PMC article. Review.
-
The Mouse Papillomavirus Epigenetic Signature Is Characterised by DNA Hypermethylation after Lesion Regression.Viruses. 2021 Oct 11;13(10):2045. doi: 10.3390/v13102045. Viruses. 2021. PMID: 34696474 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials